ClinicalTrials.gov
public full text
Public Domain
Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka#127683
- Impact of social media use on influenza vaccine hesitancy among pediatric healthcare workers: The mediating role of 3Cs.#185814
- Regorafenib Post-marketing Surveillance in Japan#1095971
- Determinants of Accepting or Rejecting Influenza Vaccination-Results of a Survey Among Ligurian Pharmacy Visitors During the 2023/2024 Vaccination Campaign#322652
- Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants#411256
Record · ID 435778
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive